Are you ready to expand abroad? Europe? Germany? Brazil? China?

The picture shows a Walmart shopping bag from Germany. Walmart’s expansion there ended in a costly failure, with losses in the billions. It’s a reminder that even companies with vast resources and top-tier logistics can fail internationally. Entering a new market takes more than scale—it takes local insight. We help you adapt, localize, and succeed. […]

Navigating International Expansion: Lessons from Walmart’s Failure in Germany

Walmart’s costly exit from the German market underscores the complexities multinational corporations face when entering foreign markets. Success demands deep adaptation to local cultural and market conditions, a strategic imperative for companies expanding internationally.

China Surpasses Harvard in Global Research Productivity: Implications from the 2025 CWTS Leiden Rankings

The 2025 CWTS Leiden Rankings reveal a significant shift in global scientific research leadership, with China’s Zhejiang University overtaking Harvard University. This development signals China’s growing dominance in research output and its broader strategic ambitions in science and technology.

Strategic Leadership for US Market Entry: The Role of Fractional CEOs in Navigating Complexity

European and German companies aiming to enter the US market face significant regulatory, cultural, and competitive challenges. Employing a fractional CEO offers a flexible, cost-effective leadership solution that provides strategic guidance and operational control without the commitment of a full-time executive.

Global Distribution and Strategic Significance of Privately Held Unicorn Companies

Privately held companies valued at over $1 billion, known as unicorns, play a pivotal role in shaping regional innovation ecosystems and global economic competitiveness. Understanding their geographic distribution offers insights into strategic industry trends and technological leadership.

China’s Pharmaceutical Industry Emerges as a Global Innovator Amid Strategic Challenges

China’s pharmaceutical sector is transitioning from a low-cost domestic producer to a significant global innovator, driven by extensive investments and a large domestic market. While regulatory and geopolitical hurdles remain, the industry is poised to accelerate its international influence and reshape global pharmaceutical competition.